165 related articles for article (PubMed ID: 3790379)
1. Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia.
Nicod P; Biollaz J; Waeber B; Goy JJ; Polikar R; Schlapfer J; Schaller MD; Turini GA; Nussberger J; Hofbauer KG
Br Heart J; 1986 Nov; 56(5):433-9. PubMed ID: 3790379
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure.
Nicod P; Waeber B; Bussien JP; Goy JJ; Turini G; Nussberger J; Hofbauer KG; Brunner HR
Am J Cardiol; 1985 Apr; 55(8):1043-7. PubMed ID: 3885704
[TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure].
Nicod P; Goy J; Waeber B; Bussien JP; Turini GA; Nussberger J; Hofbauer KG; Brunner HR
Schweiz Med Wochenschr; 1985 Dec; 115(50):1823-5. PubMed ID: 3841412
[TBL] [Abstract][Full Text] [Related]
4. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
Creager MA; Faxon DP; Cutler SS; Kohlmann O; Ryan TJ; Gavras H
J Am Coll Cardiol; 1986 Apr; 7(4):758-65. PubMed ID: 3514728
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies with a vascular vasopressin antagonist.
Waeber B; Nussberger J; Hofbauer KG; Nicod P; Brunner HR
J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S111-6. PubMed ID: 2434764
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of infused arginine vasopressin in congestive heart failure.
Goldsmith SR; Francis GS; Cowley AW; Goldenberg IF; Cohn JN
J Am Coll Cardiol; 1986 Oct; 8(4):779-83. PubMed ID: 3760354
[TBL] [Abstract][Full Text] [Related]
7. Higher Diuretic Requirements in Acute Heart Failure With Admission Hyponatraemia Versus Normonatraemia.
Omar HR; Guglin M
Heart Lung Circ; 2020 Feb; 29(2):233-241. PubMed ID: 30745014
[TBL] [Abstract][Full Text] [Related]
8. Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failure.
Stone CK; Liang CS; Imai N; Sakamoto S; Sladek CD; Hood WB
Circulation; 1988 Nov; 78(5 Pt 1):1251-9. PubMed ID: 3180381
[TBL] [Abstract][Full Text] [Related]
9. Hyponatraemia as a marker for high renin heart failure.
Levine TB; Franciosa JA; Vrobel T; Cohn JN
Br Heart J; 1982 Feb; 47(2):161-6. PubMed ID: 7037024
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study.
Ribner HS; Plucinski DA; Hsieh AM; Bresnahan D; Molteni A; Askenazi J; Lesch M
Am J Cardiol; 1985 Nov; 56(13):896-904. PubMed ID: 3904388
[TBL] [Abstract][Full Text] [Related]
11. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
Onogawa T; Sakamoto Y; Nakamura S; Nakayama S; Fujiki H; Yamamura Y
Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S67-76. PubMed ID: 22120095
[TBL] [Abstract][Full Text] [Related]
12. Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses.
Kukin ML; Kalman J; Mannino MM; Buchholz-Varley C; Ocampo O
Heart; 1997 Nov; 78(5):444-9. PubMed ID: 9415001
[TBL] [Abstract][Full Text] [Related]
13. Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure.
Berglund H; Nyquist O; Beermann B; Jensen-Urstad M; Theodorsson E
Br Heart J; 1994 Dec; 72(6):521-7. PubMed ID: 7857733
[TBL] [Abstract][Full Text] [Related]
14. Impaired response of plasma vasopressin to orthostatic stress in patients with congestive heart failure.
Goldsmith SR; Francis GS; Levine TB; Cowley AW; Cohn JN
J Am Coll Cardiol; 1983 Dec; 2(6):1080-3. PubMed ID: 6355240
[TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure.
Udelson JE; Smith WB; Hendrix GH; Painchaud CA; Ghazzi M; Thomas I; Ghali JK; Selaru P; Chanoine F; Pressler ML; Konstam MA
Circulation; 2001 Nov; 104(20):2417-23. PubMed ID: 11705818
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy.
Uretsky BF; Lawless CE; Verbalis JG; Valdes AM; Kolesar JA; Reddy PS
Chest; 1987 Oct; 92(4):657-62. PubMed ID: 3308346
[TBL] [Abstract][Full Text] [Related]
17. Does vasopressin-induced vasoconstriction persist during prolonged infusion in dogs?
Liard JF
Am J Physiol; 1987 Apr; 252(4 Pt 2):R668-73. PubMed ID: 3565599
[TBL] [Abstract][Full Text] [Related]
18. Felodipine in severe chronic congestive heart failure: acute effects on central hemodynamics and regional blood flow distribution.
Binetti G; Rubino I; Varani E; Spadoni R; Ferretti RM; Cervi V; Magnani B
Cardiovasc Drugs Ther; 1989 Dec; 3(6):903-11. PubMed ID: 2487551
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
Riegger GA; Kochsiek K
Am J Cardiol; 1986 Aug; 58(3):300-3. PubMed ID: 3526857
[TBL] [Abstract][Full Text] [Related]
20. Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy.
Manolis AJ; Olympios C; Sifaki M; Handanis S; Bresnahan M; Gavras I; Gavras H
Hypertension; 1995 Nov; 26(5):719-24. PubMed ID: 7591009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
